Sponsor content
845 result(s) found, displaying 371 to 380
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
-
Prescription medicine registrationActive ingredients: Ezetimibe, Rosuvastatin calcium.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR EVEROLIMUS everolimus 0.5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVEROCAN everolimus 1 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR EVEROLIMUS everolimus 1 mg tablet bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR EVEROLIMUS everolimus 0.25 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVEROCAN everolimus 0.25 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR EVEROLIMUS everolimus 1 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVEROCAN everolimus 0.75 mg tablet blister pack.